ABSTRACT
BACKGROUND: Patients under dialysis have a high cardiovascular risk and they are at increased risk when submitted to cardiac surgery. AIM OF THE STUDY: to evaluate morbidity, early and late mortality, and predictive factors of mortality in patients under dialysis who underwent cardiac surgery. METHODS: A retrospective observational study was performed including all dialysis dependent patients who underwent cardiac surgery (coronary, valvular or combined procedures) in our institution between 2007 and 2014. A population of 95 consecutive patients was obtained (no exclusions). Perioperative variables and predictors of mortality were analysed and the endpoints were early and late mortality. Propensity score matching, with a control group of patients with creatinine clearance >90mL/min, was performed by logistic regression, with a 1:1 matching. Kaplan Meier curves were performed for late mortality. RESULTS: Early mortality was 9.4% (EuroSCORE II 4.1%). In univariate analysis, mean time of cardiopulmonary bypass (CPB) (p=0.016) and EuroSCORE II (p=0.02) were related with early mortality. In a multivariate analysis model, combined procedures (OR 138.09; CI95% 1.82-10498.4; p=0.03) and CCS (Canadian Cardiovascular Society) 3-4 (OR 70.951; CI 95% 1.32-3810.11; p=0.037) were predictors of mortality. In multivariable analysis, CPB time >152 min was a predictor of early mortality (p=0.001). After propensity score matching, 30 day, one year and late mortality were higher in the dialysis group. CONCLUSIONS: Early and late mortality were significantly higher in dialysis dependent patients. Predictive factors of mortality were CPB time and EuroSCORE II in univariable analysis, and CCS 3-4 and combined procedures in multivariable analysis.
Subject(s)
Cardiac Surgical Procedures/mortality , Heart Diseases/surgery , Kidney Failure, Chronic/therapy , Cardiac Surgical Procedures/statistics & numerical data , Heart Diseases/complications , Humans , Kidney Failure, Chronic/complications , Renal Dialysis , Retrospective Studies , Risk Factors , Treatment OutcomeABSTRACT
Cold agglutinins (CA) are autoantibodies whose clinical significance depends upon titer and thermal amplitude. Patients, which undergo cardio-pulmonary bypass and especially hypothermic cardioplegia myocardial protection, represent a challenge regarding operative management, as tissue temperature should be maintained above the threshold of agglutination. We report on a case in which the presence of CA was discovered during elective aortic valve replacement surgery, and managed with normothermic cardiopulmonary bypass and continuous retrograde warm blood cardioplegia administration.
Subject(s)
Anemia, Hemolytic, Autoimmune/complications , Cardiopulmonary Bypass/methods , Heart Arrest, Induced/methods , Heart Valve Diseases/surgery , Hypothermia, Induced/adverse effects , Anemia, Hemolytic, Autoimmune/immunology , Aortic Valve/surgery , Autoantibodies/adverse effects , Cardiopulmonary Bypass/adverse effects , Cryoglobulins/adverse effects , Elective Surgical Procedures , Heart Arrest, Induced/adverse effects , Heart Valve Diseases/complications , Heart Valve Prosthesis Implantation/adverse effects , Heart Valve Prosthesis Implantation/methods , HumansSubject(s)
Cardiac Surgical Procedures , Pacemaker, Artificial , Vena Cava, Superior , Humans , Incidental FindingsABSTRACT
Current recommendations on the optimal revascularization strategy in Non-ST-elevation myocardial infarction (NSTEMI) with left main (LM) or multivessel coronary disease (MVD) are based upon randomized clinical trials conducted in stable coronary artery disease. In a real-world contemporary observational registry, we compared the long-term outcome of NSTEMI patients with LM/MVD (nâ¯=â¯1,104) submitted to coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or optimized medical therapy (OMT). The primary end point was 5-year all-cause mortality. Results were assessed in the entire population (CABG 289, PCI 399, and OMT 416) and in a propensity score-matched cohort of CABG (nâ¯=â¯159) and PCI (nâ¯=â¯159). Crude 5-year mortality rates in CABG and PCI were 25.3% versus 29.6%, respectively (unadjusted hazard ratio [HR] 1.2; 95% confidence intervals [CI] 0.9 to 1.6; p = 0.212); OMT, however, was associated with a twofold higher risk of mortality when compared with any revascularization strategy (unadjusted HR 2.0; 95% CI 1.7 to 2.5; p < 0.001). After propensity score-matching and multivariate analysis, there was a trend toward a higher incidence of the primary end point in patients who underwent PCI versus CABG (31% vs 21%; adjusted HR 1.52; 95% CI 0.93 to 2.50; p = 0.094). This was a consistent finding over subgroups deemed clinically relevant, such as in patients with LM or proximal left anterior descending disease, SYNergy between percutaneous coronary intervention with TAXus ≥23 and left ventricle ejection fraction <40%. In conclusion, in a real-world cohort of NSTEMI patients with LM/MVD, those selected for OMT had a dire outcome. Although adjusted 5-year mortality was statistically similar between revascularization strategies, there was a trend favoring CABG, which might be the preferred option in LM, proximal LAD, SYNergy between percutaneous coronary intervention with TAXus ≥23, and left ventricle ejection fraction <40% subgroups.
Subject(s)
Coronary Artery Bypass/methods , Coronary Vessels/diagnostic imaging , Non-ST Elevated Myocardial Infarction/surgery , Percutaneous Coronary Intervention/methods , Propensity Score , Registries , Aged , Aged, 80 and over , Coronary Angiography , Coronary Vessels/surgery , Female , Follow-Up Studies , Humans , Male , Middle Aged , Non-ST Elevated Myocardial Infarction/diagnosis , Retrospective Studies , Treatment OutcomeABSTRACT
INTRODUCTION: Over the past 3 decades two main strategies have been employed for surgical coronary revascularization (CABG): on- pump CABG with cardioplegia (ONCAB) and off-pump CABG (OPCAB). The objective of this study is to evaluate the short-term and long-term survival of the two strategies. METHODS: This study consists of 8-year cohort, retrospective single-center analysis with an intention-to-treat design. 2954 patients underwent CABG (OPCAB n=2123; ONCAB= 831) for CAD. As these two groups were statistically different regarding several parameters, a propensity score model was applied and a more homogeneous cohort (n= 1441; OPCAB= 885; ONCAB=556) was analyzed. Univariate analysis, Kaplan-Meier curves and when appropriate a multivariate analysis was applied to the overall group and 6 subgroups: 2 vessel disease, 3 vessel disease, left stem disease, diabetic patients; patients with creatinin clearance bellow 50ml/min; and patients with body mass index above 30 kg/m2. RESULTS: Our study show: No difference in 30-days mortality, long-term survival (mean 71 months follow-up), AKY and stroke rates; Higher rates of bypass per patient (2.3% vs 2.8%, p<0,001) and complete revascularization (76% vs 83%) in the ONCAB group; Fewer re-operation for bleeding (0.8 vs 3.8%, p<0.001), fewer peak troponin>19mg/ dl (4.7% vs 9.9%, p<0,001), and fewer IABP use (1.5% vs 3.3%, p=0,027) in the OPCAB group. Sub-group analysis showed no difference between the two groups with exception of a higher rate of troponin peak >19mg/dl adjusted for CAD extension in the left-main stem disease group undergoing ONCAB (OR=2,3 +-0.8 p=0,018). CONCLUSION: The major randomized controlled trials comparing the two strategies show: No difference in 30-days mortality, 1-year survival, AKY and stroke rates; Less re-revascularization rates and higher bypass per patient and bypass patency with ONCAB. Despite the large volume of evidence generated around both on-pump and off-pump CABG strategies, studies fail to demonstrate clear benefit of either strategy regarding mortality and most common complications. Our results are similar of those found in the literature as neither strategy has unequivocal superior results. ONCAB shows consistently higher rates of complete revascularization and higher number of grafts. OPCAB shows lesser troponin levels suggestive of less myocardial damage. Major limitations include: analysis not matched for surgeon performance; cardiac related events, re-revascularization need and graft patency not evaluated; isolated use of troponin levels for evaluation myocardial damage.
Subject(s)
Coronary Artery Bypass, Off-Pump , Coronary Artery Disease , Coronary Artery Bypass , Coronary Artery Disease/surgery , Humans , Propensity Score , Reoperation , Retrospective Studies , Treatment OutcomeABSTRACT
INTRODUCTION: Left heart disease is the most common cause of pulmonary hypertension (PH), and when present is associated with higher surgical risk. OBJECTIVES: Analyze the effect of PH severity on morbidity, early and late mortality in patients with pulmonary artery systolic pressure (PASP) over 30mmHg that underwent valvular heart surgery. METHODS: Retrospective observational study including all patients with PH, defined as PASP>30 mmHg that underwent isolated valvular heart surgery, between 2007 and 2016. Exclusion criteria were: active endocarditis, congenital heart disease, transcatheter aortic valve implantation, reoperations and emergent surgery. The study population included 607 patients with a mean age of 69.6 years and a mean PASP of 52.5 mmHg. Mean follow-up for all-cause mortality was 4.4(0-11) years in 99.7% of patients. MACCE (Major Adverse Cardiac and Cerebrovascular event) was defined as at least one of the following: in-hospital mortality, stroke, post-operative myocardial infarction, severe arrhythmia or multiple organ failure. PASP was evaluated as a continuous variable. Simple and multivariable logistic regression was performed to evaluate the in-hospital mortality and MACCE. Cox regression was used for long term follow-up and one-sample log-rank test for comparison with age adjusted general population. RESULTS: The in-hospital mortality was 3.2% and PASP was an independent predictor on univariable analysis (OR:1.06; 95%CI:1.03- 1.09; p<0.001). On multivariable logistic regression PH remains an independent predictor of in- -hospital mortality (OR:1.08; 95%CI:1.04-1.12; p<0.001) in addition to age (OR:1.08; 95%CI:1.01-1.17; p=0.044). MACCE was observed in 11.4% and PASP was an independent predictor on univariable analysis (OR:1.03; 95%CI:1.01- 1.04; p<0.001). On multivariable logistic regression PASP remains an independent predictor of MACCE (OR:1.02; 95%CI:1.01-1.04; p=0.011) as well as hemodialysis (OR:7.16; 95%CI:1.73-29.63; p=0.007). The independent predictors of long term mortality were male gender (p=0.011), older age (p<0.001), higher body mass index (p=0.013), urgent surgery (p=0.027), pulmonary disease (p=0.042) and more than one valve procedure (p=0.004 for 2 valves and p=0.006 for 3 valves). PASP was not an independent predictor of long term mortality (p=0.142). Compared with an age adjusted general population, patients with PH had a significantly lower survival rate(p<0.001), more evident 4 years after the procedure. CONCLUSIONS: Higher PASP is a risk factor for in-hospital mortality and MACCE, but there was no significant impact on long term mortality.
Subject(s)
Heart Valve Diseases , Heart Valve Prosthesis Implantation , Hypertension, Pulmonary , Aged , Aortic Valve , Female , Heart Valve Diseases/complications , Heart Valve Diseases/surgery , Humans , Hypertension, Pulmonary/complications , Male , Prognosis , Retrospective Studies , Risk FactorsSubject(s)
Heart Neoplasms , Myxoma , Vena Cava, Inferior , Heart Neoplasms/surgery , Humans , Myxoma/surgery , Stents , Vena Cava, Inferior/surgeryABSTRACT
OBJECTIVES: To analyze the influence of surgical myocardial revascularization on early and late mortality in octogenarians and compare the survival rates with age adjusted general population. METHODS: Between 2007 and 2014, 182 octogenarian patients underwent elective or urgent coronary artery bypass grafting surgery. Logistic regression was performed to evaluate the in-hospital mortality predictors. The comparison of long term survival between our population and age adjusted general population was made using one-sample log-rank test. RESULTS: The in-hospital mortality was 4,4% and its predictors on univariable analysis were non sinus rhythm (p=0,001), acute coronary syndrome less than 7 days prior to surgery (p=0,021), ejection fraction less than 50% (p=0,04) and the need for conversion to on pump surgery (p=0,04). On multivariate logistic regression non sinus rhythm and acute myocardial infarction less than 7 days before surgery were independent predictors of in-hospital mortality. Follow-up at one-year showed survival rate of 86,2% and at five years 58,4%. There was no significant difference in survival rates between the study group and the age adjusted standard population (p=0,96). The group was divided in two groups: (1) complete revascularization and (2) incomplete revascularization. There was no significant difference in survival (p=0,32 and p=0,19, respectively) compared to the age adjusted standard population. CONCLUSIONS: Coronary artery bypass grafting in octogenarians is safe and has an important impact on long term survival, with five-year survival being similar to the age adjusted standard population.
Objetivos: Analisar o impacto da revascularização miocárdica cirúrgica na mortalidade precoce e tardia em octogená- rios e comparar a sobrevida com a população geral ajustada para a idade. Métodos: Entre 2007 e 2014, 182 octogenários foram submetidos a cirurgia de revascularização miocárdica eletiva ou urgente. Utilizou-se regressão logística para avaliar os preditores de mortalidade intra-hospitalar. A comparação da sobre- vivência a longo prazo entre a população em estudo e a população ajustada para a idade efetuou-se com o teste one sample log-rank. Resultados: A mortalidade intra-hospitalar foi 4,4% e os seus preditores, na análise univariável, foram ritmo não sinusal (p=0,001), síndrome coronário agudo menos de 7 dias antes da cirurgia (p=0,021), fração de ejeção menos de 50% (p=0,04) e conversão em cirurgia on pump (p=0,04). Na análise multivariada, o ritmo não sinusal e síndrome coronário agudo menos de 7 dias antes da cirurgia foram preditores independentes de mortalidade intra-hospitalar. No seguimento a um ano a sobrevivência foi de 86,2% e a cinco anos de 58,4%. Não se verificou diferença significativa na sobrevivência entre o grupo de estudo e a população geral ajustada para a idade (p=0,96). A população em estudo foi dividida em dois grupos: (1) revascula- rização completa e (2) revascularização incompleta. Não se verificou diferença significativa (p=0,32 e p=0,19, respetivamente) quando comparados com a população geral ajustada para a idade. Conclusão: A cirurgia de revascularização miocárdica em octogenários é segura e tem um importante impacto na sobrevida a longo prazo, com sobrevivência a cinco anos semelhante à população geral ajustada para a idade.
ABSTRACT
Sustained tachycardia is a rare, usually reversible, cause of dilated cardiomyopathy. Extracorporeal membrane oxygenation (ECMO) is a useful method for cardiopulmonary resuscitation and short-term support for reversible cardiac failure refractory to conventional therapy. The present case consists of a 17-years-old male who presented with symptoms of cardiac insufficiency and tachycardia. Timely extracorporeal circulatory assistance with venous-arterial ECMO was essential to patient stabilization, tachycardia control as well as recognition and ablation of culprit ventricular-atrial posterior-septal accessory pathway. The patient's steady hemodynamic and left ventricular function improvement was documented and extracorporeal circulatory assistance was discontinued 1 week after implantation.
ABSTRACT
INTRODUCTION: As surgical revascularization is becoming more frequent in octogenarians, we reviewed our data to analyze the impact of coronary artery bypass grafting on short- and long-term morbidity and mortality. METHODS: We performed a retrospective study of 101 consecutive patients aged 80 years or older, who underwent coronary artery bypass in a single cardiac center between January 2002 and December 2007. The patients were divided into two groups: off-pump (64.4%) and on-pump (35.6%), depending on whether the surgery was performed with cardiopulmonary bypass. Early results and those up to 6 years after surgery were assessed. RESULTS: Baseline characteristics were similar between the groups and follow-up was 90% complete. There were no significant differences between groups in mean age (off-pump = 82.7 +/- 18 years vs. on-pump = 82.2 +/- 2.2 years; p = NS) or in logistic EuroSCORE (off-pump = 11.2 +/- 12.3 vs. on-pump = 8.5 +/- 5.1; p = NS). However, the off-pump group had less complete revascularization (off-pump = 43.1% vs. on-pump = 83.3%, p = 0.0001) and shorter mean hospital stay (off-pump = 9.3 +/- 5.4 days vs. on-pump = 11.5 +/- 7.3 days; p = 0.09). Both groups showed low hospital mortality (off-pump = 1.5% vs. on-pump = 2.8%, p = NS). At 6-year follow-up, off-pump surgery patients had the same late prognosis (total survival: off-pump = 80% vs. on-pump = 77.4%, p = NS; cardiovascular mortality: off-pump = 15% vs. on-pump = 16.1%, p = NS). CONCLUSION: In octogenarians coronary artery bypass grafting had excellent results. The off-pump technique, even though it can mean less complete revascularization, leads to shorter hospital stay and has the same 6-year results as in patients operated under cardiopulmonary bypass.